Skip to main content
. 2015 May 1;8(5):4869–4880.

Figure 1.

Figure 1

Identification of differential expression of miR-302a in human ovarian cancer. A. We use quantitative Real-time PCR to detect miR-302a differential expression level in human ovarian cancer cells (C13K, 3AO, SKOV3 and OVCAR3) and normal cells. U6 snRNA was regarded as an endogenous normalizer and the relative miR-302a expression level of the 4 kinds of human ovarian cancer cells (means ± SD) is shown (*P < 0.05). B. We use Northern blot and Western blot to detect miR-302a and SDC1 differential expression level in 7 human ovarian cancer tissue samples (*P < 0.05). C. We use quantitative Real-time PCR to detect miR-302a differential expression level in human ovarian cancer stage III/IV tissue samples and the stage I/II ones (*P < 0.05). D. We use Western blot to detect SDC1 differential expression level in human ovarian cancer stage III/IV tissue samples and the stage I/II ones (*P < 0.05).